Weekly Brief / Issue 04

China Capital Markets Weekly: Chip Growth Meets the Cash Flow Test

Calterah's new STAR Market application pairs rapid radar-chip growth with losses and uneven cash generation

5 min read

Pencil illustration of an automotive radar module and engineering test bay
Calterah 2025 revenueCNY632.23mCompared with CNY303.32m in 2024
2025 net lossCNY192.59mConsolidated result
Q1 2026 operating cash flow−CNY120.54mA three-month period

Calterah entered the IPO pipeline with revenue that more than doubled in 2025, but remained loss-making. Its application arrives alongside the CSRC's annual accounting review, which explains why sales growth must be read with acceptance terms, expenditure recognition and asset values.

Contents

Radar-chip growth has a cash-flow test

Calterah's STAR Market application was accepted on August 13. The automotive radar and ultra-wideband chip designer reported CNY632.23 million of revenue for 2025, more than twice its 2024 sales. Its net loss narrowed to CNY192.59 million. Operating cash outflow also improved substantially, before widening again in the first quarter of 2026.

The application gives investors an early view of a rapidly expanding semiconductor business that has not yet reached profitability. The CSRC's annual accounting review, published the following day, provides a useful companion: reported growth depends on how contracts, costs and assets are accounted for, not simply on whether a product serves a promising market.

Calterah: revenue growth, losses and cash outflows. Calterah prospectus, 13 August 2026; annual figures, CNY million.
Calterah: revenue growth, losses and cash outflowsSource: Calterah prospectus, 13 August 2026; annual figures, CNY million.

A new applicant under STAR Market's fourth standard

Calterah follows a fabless model: it designs chips while relying on external manufacturing services rather than owning a complete fabrication operation. Its products include millimeter-wave radar chips used in automotive sensing and ultra-wideband technology.

The application uses STAR Market's fourth standard, with an expected market capitalization of at least CNY3 billion and at least CNY300 million of revenue in the latest year, alongside the applicable requirements. This route does not require current profitability. It still requires a credible account of the business, its technology and the risks in its financial model.

CNY million 2023 2024 2025 Q1 2026
Revenue 205.98 303.32 632.23 154.44
Net profit / loss -323.36 -333.99 -192.59 -60.29
Adjusted profit / loss -291.54 -342.20 -197.14 -65.84
Operating cash flow -170.42 -248.63 -18.47 -120.54
R&D spending / revenue 147.75% 120.17% 58.55% 63.67%

Source: Calterah's August 13 prospectus, financial overview. The quarterly figures are not annualized.

The lower R&D-to-revenue ratio reflects a much larger sales base; it does not establish that the company has reduced the resources needed to develop chips. Similarly, the improvement in 2025 operating cash flow cannot be assumed to recur from the annual number alone. Collection timing, inventory purchases and supplier payments can change the cash profile of a fabless business even without a factory construction program.

Calterah proposes raising CNY3.489 billion: roughly CNY2.093 billion for radar development, CNY694.85 million for ultra-wideband work and CNY702.06 million for headquarters and research facilities. The total is approximately 5.5 times 2025 revenue. That is a comparison of scale, not a claim that the plan is excessive. It shows the extent to which the application depends on future products and future sales.

Issuer-cited market research assigns the company a 4% global share and a 31.1% domestic share in the relevant market. Those estimates help place the business, but their category definitions and measurement basis matter. They should not be read as a regulator's endorsement of the company's prospects.

The accounting review explains where growth can be misread

The CSRC's August 14 report reviews listed companies' annual financial reporting. It discusses issues including principal-versus-agent revenue presentation, acceptance conditions, substantive installation work, costs, impairment and capitalized development spending. It is a regulatory review of reporting practices, not a newly issued accounting standard or a finding against Calterah.

The principal-versus-agent distinction can change the apparent size of a business. A company acting as principal generally presents the relevant sales and costs gross; an agent may recognize only its fee. The economic question is which party controls the goods or service before delivery, not which party issued the invoice.

Acceptance and installation matter for the timing of revenue. If substantial work remains before a customer obtains control, shipment alone may not complete the obligation. A growing year-end balance of receivables or contract assets should be read with those terms. Capitalized development spending requires a different assessment: whether the conditions for recognizing an asset are met and whether future benefits support its carrying amount.

For readers, these are ways to interpret the accounts, not grounds to presume misconduct. The report's value is that it points to the contractual and operational evidence behind the numbers.

Inquiry replies connect capacity with customers

Xintong Pharma's response runs to about 440 pages and addresses fourteen groups of questions, including licensed technology, internally developed capabilities and core pipelines. For a drug developer, licensing a promising product does not settle questions about control of the rights, future payments or the evidence required to reach later regulatory milestones.

Autotuo's reply covers eight groups of questions. Youbang's reply connects a proposed capacity increase with a major customer relationship, including Foxconn. Tiejin's response covers five groups across roughly 314 pages. These filings illustrate why a capacity plan needs more than a large addressable-market estimate. Customers must be able and willing to buy, qualification must translate into orders, and the economics must support the proposed equipment and staffing.

Beijing exchange developments included committee passes for Tianguangshi and Hongyi, and registration submissions by Huaneng Turbine and Fangyi. Registration approvals for Bairuiji and Century Digital appeared on August 14, although the underlying decisions were dated July 31. Yangguang's withdrawal led to termination; withdrawals and terminations should not be described as committee rejections without the decision saying so.

Exchange supervision distinguishes conduct from market performance

Shenzhen's August 10–14 bulletin reported action on 114 abnormal trading incidents, eight checks concerning major company matters and two suspected-violation leads sent to the CSRC. It also reported oral warnings concerning research reports at two firms. These are different supervisory actions, not a combined count of final penalties.

The relevance to intermediaries is practical. A research claim needs a basis; a prospectus forecast needs support; an accounting conclusion needs the contract and the underlying performance evidence. The same discipline helps investors evaluate Calterah's next phase: whether new sales fund the development cycle, or whether growth continues to depend on additional capital.

Sources

Disclaimer

This article examines public records relating to the reporting period. It is for research and educational purposes and is not investment, legal or accounting advice, or a recommendation concerning any security. Official findings are attributed to the relevant authority; analytical observations are not findings of misconduct. Public documents may subsequently be corrected or supplemented.

Figure